AA
MDT icon

AlphaCentric Advisors’s Medtronic MDT Stock Holding History

AlphaCentric Advisors’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,000
Closed -$450K – 257
2024
Q3 		$450K Sell
5,000
-12,500
-71% -$1.05M 0.33% 79
2024
Q2 		$1.38M Sell
17,500
-3,000
-15% -$246K 1.01% 29
2024
Q1 		$1.79M Hold
20,500
– – 1.08% 30
2023
Q4 		$1.69M Buy
20,500
+16,500
+413% +$1.26M 1.13% 28
2023
Q3 		$313K Hold
4,000
– – 0.18% 113
2023
Q2 		$352K Hold
4,000
– – 0.2% 110
2023
Q1 		$322K Hold
4,000
– – 0.22% 103
2022
Q4 		$311K Buy
+4,000
New +$324K 0.31% 93

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AlphaCentric Advisors's MDT Position: Q4 2024 in Review

AlphaCentric Advisors sold out of Medtronic (MDT) in Q4 2024, closing a stake of 5,000 shares — an estimated $450K sold.

AlphaCentric Advisors first reported a position in MDT in Q4 2022 and held it in 8 quarters. The position peaked at $1.79M in Q1 2024. 2,123 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • AlphaCentric Advisors reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
  • AlphaCentric Advisors sold 5,000 Medtronic shares in Q4 2024, an estimated $450K.
  • AlphaCentric Advisors first reported a position in Medtronic in Q4 2022 and held it in 8 quarters.
  • AlphaCentric Advisors's Medtronic position peaked at $1.79M in Q1 2024.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.